Skip to content

Effects of an Online Meditation Course on Quality of Life

Effects of an Online Meditation Course on Quality of Life and Positive Emotions - a Prospective Observational Study (EXPAN Study)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04950543
Enrollment
374
Registered
2021-07-06
Start date
2021-07-05
Completion date
2021-10-17
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life

Keywords

Meditation

Brief summary

Many interventions in the field of meditation are becoming increasingly popular and have gained worldwide acceptance over the past years, both in terms of health, but also psychological aspects. On the other hand, controversial and sometimes hypercritical positions are on the rise, questioning the positive effects of meditation on health due to the limited availability of high-quality scientific data. With regard to a large number of meditation interventions, the systematic exploration of procedures that have not yet been scientifically evaluated - also in online settings - is a meaningful contribution to meditation research.

Interventions

BEHAVIORALMeditation

An online survey will be offered to participants who have enrolled in a 21-day meditation online course. The survey will be conducted using mobile website technology before and after the online course and additionally after 3 and 6 months.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 years or older * All persons registering for the online course * Internet access * Sufficient language skills, as well as cognitive and physical abilities, to participate in an online survey lasting approximately 30 minutes * Active consent to the online consent form

Exclusion criteria

\- Failure to provide informed consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Quality of life, PROMIS-29 Profile v2.1Change from Baseline Quality of life at 1 monthsThe scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.

Secondary

MeasureTime frameDescription
Quality of life, PROMIS-29 Profile v2.1Baseline, 3 months and 6 monthsThe scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Global Health, PROMIS Scale v1.2Baseline, 1 month, 3 months and 6 monthsThe scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Affect regulation, PANAS 10Baseline, 1 month, 3 months and 6 monthsThe scale ranges from 1 to 5, where 1 is the lowest level and 5 is the highest level.
Stress, PSS 4Baseline, 1 month, 3 months and 6 monthsThe scale ranges from 0 to 16, where 0 is the lowest level and 16 is the highest level.
Flourishing, FS 8Baseline, 1 month, 3 months and 6 monthsThe scale ranges from 8 to 56, where 8 is the lowest level and 56 is the highest level.
Resilience, CD-RISC 10Baseline, 1 month, 3 months and 6 monthsThe scale ranges from 0 to 4, where 0 is the lowest level and 40 is the highest level.
Mysticism, HMS-8Baseline, 1 month, 3 months and 6 monthsThe scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Awe and Gratitude, GrAw-7Baseline, 1 month, 3 months and 6 monthsThe scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Spirituality, ASPBaseline, 1 month, 3 months and 6 monthsThe scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Sedentary behaviorBaseline, 1 month, 3 months and 6 monthsDuration in minutes
Sporting activityBaseline, 1 month, 3 months and 6 monthsDuration in minutes
Relaxation behaviorBaseline, 1 month, 3 months and 6 monthsDuration in minutes
Alcohol consumptionBaseline, 1 month, 3 months and 6 monthsAssessed retrospectively (last 1 month) with self-designed question
CigarettesBaseline, 1 month, 3 months and 6 monthsAssessed retrospectively (last 1 month) with self-designed question
Self-efficacy, ASKUBaseline, 1 month, 3 months and 6 monthsThe scale ranges from 1 to 5, where 1 is the lowest level and 5 is the highest level.

Other

MeasureTime frame
Qualitative interviews1 month and 6 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026